On February 9, 2022 Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, reported that its Chairman and Chief Executive Officer, Kevin Hrusovsky, will present virtually at the SVB Leerink Global Healthcare Conference on Feb. 16 at 4:20 p.m., EST (Press release, Quanterix, FEB 9, 2022, View Source [SID1234607923]). To register for the live webcast, please visit View Source;page=qtrx&url=View Source

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of the presentation will be available on the investor section of the Quanterix website at View Source Replays of the webcast will be available on the Quanterix website for 90 days following the conference. Hrusovsky will also host virtual one-on-one meetings with institutional investors on Feb. 18.